• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多形性胶质母细胞瘤(GBM)中的微小RNA(miRNA)——近期文献综述

microRNAs (miRNAs) in Glioblastoma Multiforme (GBM)-Recent Literature Review.

作者信息

Makowska Marianna, Smolarz Beata, Romanowicz Hanna

机构信息

Department of Anesthesiology and Operative Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.

Laboratory of Cancer Genetics, Department of Pathology, Polish Mother's Memorial Hospital Research Institute, Rzgowska 281/289, 93-338 Lodz, Poland.

出版信息

Int J Mol Sci. 2023 Feb 9;24(4):3521. doi: 10.3390/ijms24043521.

DOI:10.3390/ijms24043521
PMID:36834933
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9965735/
Abstract

Glioblastoma multiforme (GBM) is the most common, malignant, poorly promising primary brain tumor. GBM is characterized by an infiltrating growth nature, abundant vascularization, and a rapid and aggressive clinical course. For many years, the standard treatment of gliomas has invariably been surgical treatment supported by radio- and chemotherapy. Due to the location and significant resistance of gliomas to conventional therapies, the prognosis of glioblastoma patients is very poor and the cure rate is low. The search for new therapy targets and effective therapeutic tools for cancer treatment is a current challenge for medicine and science. microRNAs (miRNAs) play a key role in many cellular processes, such as growth, differentiation, cell division, apoptosis, and cell signaling. Their discovery was a breakthrough in the diagnosis and prognosis of many diseases. Understanding the structure of miRNAs may contribute to the understanding of the mechanisms of cellular regulation dependent on miRNA and the pathogenesis of diseases underlying these short non-coding RNAs, including glial brain tumors. This paper provides a detailed review of the latest reports on the relationship between changes in the expression of individual microRNAs and the formation and development of gliomas. The use of miRNAs in the treatment of this cancer is also discussed.

摘要

多形性胶质母细胞瘤(GBM)是最常见、恶性程度高且预后不佳的原发性脑肿瘤。GBM的特征在于浸润性生长特性、丰富的血管生成以及快速且侵袭性的临床病程。多年来,胶质瘤的标准治疗一直是手术治疗辅以放疗和化疗。由于胶质瘤的位置以及其对传统疗法的显著抗性,胶质母细胞瘤患者的预后非常差且治愈率低。寻找新的治疗靶点和有效的癌症治疗工具是医学和科学当前面临的挑战。微小RNA(miRNA)在许多细胞过程中发挥关键作用,如生长、分化、细胞分裂、细胞凋亡和细胞信号传导。它们的发现是许多疾病诊断和预后方面的一项突破。了解miRNA的结构可能有助于理解依赖miRNA的细胞调控机制以及这些短非编码RNA相关疾病的发病机制,包括胶质脑肿瘤。本文详细综述了关于单个微小RNA表达变化与胶质瘤形成和发展之间关系的最新报道。还讨论了miRNA在这种癌症治疗中的应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b282/9965735/3492f2326131/ijms-24-03521-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b282/9965735/f07635e58218/ijms-24-03521-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b282/9965735/b1f1987daaa0/ijms-24-03521-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b282/9965735/3492f2326131/ijms-24-03521-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b282/9965735/f07635e58218/ijms-24-03521-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b282/9965735/b1f1987daaa0/ijms-24-03521-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b282/9965735/3492f2326131/ijms-24-03521-g003.jpg

相似文献

1
microRNAs (miRNAs) in Glioblastoma Multiforme (GBM)-Recent Literature Review.多形性胶质母细胞瘤(GBM)中的微小RNA(miRNA)——近期文献综述
Int J Mol Sci. 2023 Feb 9;24(4):3521. doi: 10.3390/ijms24043521.
2
Differential expression of MicroRNAs in patients with glioblastoma after concomitant chemoradiotherapy.胶质母细胞瘤患者同步放化疗后 MicroRNAs 的差异表达。
OMICS. 2013 May;17(5):259-68. doi: 10.1089/omi.2012.0065. Epub 2013 Apr 15.
3
miRNA Multiplayers in glioma. From bench to bedside.胶质瘤中的微小RNA多面手。从实验室到临床。
Acta Biochim Pol. 2015;62(3):353-65. doi: 10.18388/abp.2015_1072. Epub 2015 Aug 26.
4
The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness.肿瘤抑制性微小RNA-218在靶向胶质母细胞瘤干性方面的新作用。
Cancer Lett. 2014 Oct 10;353(1):25-31. doi: 10.1016/j.canlet.2014.07.011. Epub 2014 Jul 17.
5
MicroRNAs as Multifaceted Players in Glioblastoma Multiforme.微小 RNA 作为多形性胶质母细胞瘤的多面手。
Int Rev Cell Mol Biol. 2017;333:269-323. doi: 10.1016/bs.ircmb.2017.03.002. Epub 2017 Apr 21.
6
Molecular mechanisms of microRNAs in glioblastoma pathogenesis.miRNAs 在胶质母细胞瘤发病机制中的分子机制。
Biochim Biophys Acta Mol Cell Res. 2023 Aug;1870(6):119482. doi: 10.1016/j.bbamcr.2023.119482. Epub 2023 May 3.
7
MicroRNAs involved in the EGFR pathway in glioblastoma.胶质母细胞瘤中涉及 EGFR 通路的 microRNAs。
Biomed Pharmacother. 2021 Feb;134:111115. doi: 10.1016/j.biopha.2020.111115. Epub 2020 Dec 16.
8
Propolis Extract Regulates microRNA Expression in Glioblastoma and Brain Cancer Stem Cells.蜂胶提取物调节脑胶质瘤和脑肿瘤干细胞中的 microRNA 表达。
Anticancer Agents Med Chem. 2022;22(2):378-389. doi: 10.2174/1871520621666210504082528.
9
Human tissue engineering allows the identification of active miRNA regulators of glioblastoma aggressiveness.人体组织工程学允许鉴定胶质母细胞瘤侵袭性的活跃 miRNA 调节因子。
Biomaterials. 2016 Nov;107:74-87. doi: 10.1016/j.biomaterials.2016.08.009. Epub 2016 Aug 24.
10
miRNAs as important drivers of glioblastomas: a no-brainer?miRNAs 作为胶质母细胞瘤的重要驱动因素:这是显而易见的吗?
Cancer Biomark. 2012;11(6):245-52. doi: 10.3233/CBM-2012-0271.

引用本文的文献

1
The role and therapeutic value of NUSAP1 in human cancers.NUSAP1在人类癌症中的作用及治疗价值。
J Transl Med. 2025 Jul 2;23(1):725. doi: 10.1186/s12967-025-06746-2.
2
Recent advances in molecular mechanisms of microRNAs in pathogenesis and resistance of treatment in glioblastoma.微小RNA在胶质母细胞瘤发病机制及治疗耐药性中的分子机制研究进展
Clin Transl Oncol. 2025 Jun 24. doi: 10.1007/s12094-025-03969-z.
3
Liquid Biopsy as a Diagnostic and Monitoring Tool in Glioblastoma.液体活检作为胶质母细胞瘤的诊断和监测工具

本文引用的文献

1
Comparing tumor microRNA profiles of patients with long‑ and short‑term‑surviving glioblastoma.比较长生存期和短生存期胶质母细胞瘤患者的肿瘤 microRNA 图谱。
Mol Med Rep. 2023 Jan;27(1). doi: 10.3892/mmr.2022.12895. Epub 2022 Nov 11.
2
Emerging role of extracellular vesicles in the pathogenesis of glioblastoma.细胞外囊泡在胶质母细胞瘤发病机制中的新作用
Metab Brain Dis. 2023 Jan;38(1):177-184. doi: 10.1007/s11011-022-01074-6. Epub 2022 Sep 9.
3
Role of MicroRNA-7 (MiR-7) in Cancer Physiopathology.微小 RNA-7(MiR-7)在癌症病理生理学中的作用。
Medicina (Kaunas). 2025 Apr 13;61(4):716. doi: 10.3390/medicina61040716.
4
MSC-derived extracellular vesicles: Precision miRNA delivery for overcoming cancer therapy resistance.间充质干细胞衍生的细胞外囊泡:用于克服癌症治疗耐药性的精准miRNA递送
Regen Ther. 2025 Apr 1;29:303-318. doi: 10.1016/j.reth.2025.03.006. eCollection 2025 Jun.
5
The Clinical Role of miRNAs in the Development and Treatment of Glioblastoma.微小RNA在胶质母细胞瘤发生发展及治疗中的临床作用
Int J Mol Sci. 2025 Mar 18;26(6):2723. doi: 10.3390/ijms26062723.
6
Exosome-based miRNA delivery: Transforming cancer treatment with mesenchymal stem cells.基于外泌体的微小RNA递送:用间充质干细胞改变癌症治疗
Regen Ther. 2025 Feb 13;28:558-572. doi: 10.1016/j.reth.2025.01.019. eCollection 2025 Mar.
7
Diagnostic and Prognostic Values of miRNAs in High-Grade Gliomas: A Systematic Review.微小RNA在高级别胶质瘤中的诊断和预后价值:一项系统综述
F1000Res. 2025 Jan 15;13:796. doi: 10.12688/f1000research.151350.2. eCollection 2024.
8
Hydrogel-based nanoparticles: revolutionizing brain tumor treatment and paving the way for future innovations.基于水凝胶的纳米颗粒:革新脑肿瘤治疗并为未来创新铺平道路。
Eur J Med Res. 2025 Feb 4;30(1):71. doi: 10.1186/s40001-025-02310-2.
9
Unveiling cell-type-specific microRNA networks through alternative polyadenylation in glioblastoma.通过胶质母细胞瘤中的可变多聚腺苷酸化揭示细胞类型特异性微小RNA网络
BMC Biol. 2025 Jan 21;23(1):15. doi: 10.1186/s12915-024-02104-8.
10
Expression of some circulating microRNAs as predictive biomarkers for prognosis and treatment response in glioblastoma.某些循环微RNA作为胶质母细胞瘤预后和治疗反应预测生物标志物的表达
Sci Rep. 2025 Jan 14;15(1):1933. doi: 10.1038/s41598-024-83800-x.
Int J Mol Sci. 2022 Aug 13;23(16):9091. doi: 10.3390/ijms23169091.
4
Neurotransmitters: Potential Targets in Glioblastoma.神经递质:胶质母细胞瘤的潜在靶点。
Cancers (Basel). 2022 Aug 17;14(16):3970. doi: 10.3390/cancers14163970.
5
WHO CNS5 2021 classification of gliomas: a practical review and road signs for diagnosing pathologists and proper patho-clinical and neuro-oncological cooperation.世界卫生组织 CNS5 2021 年胶质瘤分类:病理学家实用解读及诊断路标,以及恰当的病理临床与神经肿瘤学合作。
Folia Neuropathol. 2022;60(2):137-152. doi: 10.5114/fn.2022.118183.
6
Recent insights into the microRNA-dependent modulation of gliomas from pathogenesis to diagnosis and treatment.从发病机制到诊断和治疗,深入了解 microRNA 调控胶质瘤的最新研究进展。
Cell Mol Biol Lett. 2022 Aug 3;27(1):65. doi: 10.1186/s11658-022-00354-4.
7
Potential Neurotoxic Effects of Glioblastoma-Derived Exosomes in Primary Cultures of Cerebellar Neurons via Oxidant Stress and Glutathione Depletion.胶质母细胞瘤来源的外泌体通过氧化应激和谷胱甘肽耗竭对小脑神经元原代培养物产生的潜在神经毒性作用。
Antioxidants (Basel). 2022 Jun 23;11(7):1225. doi: 10.3390/antiox11071225.
8
Role of Circular RNA in Brain Tumor Development.环状 RNA 在脑肿瘤发展中的作用。
Cells. 2022 Jul 6;11(14):2130. doi: 10.3390/cells11142130.
9
Therapeutic strategies of glioblastoma (GBM): The current advances in the molecular targets and bioactive small molecule compounds.胶质母细胞瘤(GBM)的治疗策略:分子靶点与生物活性小分子化合物的当前进展
Acta Pharm Sin B. 2022 Apr;12(4):1781-1804. doi: 10.1016/j.apsb.2021.12.019. Epub 2021 Dec 31.
10
MicroRNAs as prognostic markers and therapeutic targets in gliomas.微小RNA作为胶质瘤的预后标志物和治疗靶点
Noncoding RNA Res. 2022 Jul 6;7(3):171-177. doi: 10.1016/j.ncrna.2022.07.001. eCollection 2022 Sep.